DoubleTree Hotel and Executive Meeting Center , Bethesda, MD
Oct 13 2010 8:00AM - Oct 14 2010 5:00PM
Join Leaders from Industry, Academia, CDC, FDA, EMA, and WHO to Discuss Emerging Topics in Maternal and Pediatric Drug Safety. Maternal and pediatric drug safety is becoming increasingly important areas in the life cycle of medical compounds. Recent regulatory guidelines and scientific findings have emphasized the need to collect, analyze, and report data of the highest quality to healthcare providers and patients. You will leave this symposium with a solid understanding of: • Scientific challenges of maternal and pediatric drug safety
• Pros and cons of various methods of drug safety assessment in pregnancy, lactation, and pediatrics
• Recent regulatory actions in the maternal and pediatric areas
• How to assess maternal and pediatric drug safety
• Situations where the benefits of vaccination during pregnancy outweigh the potential risks
• When a lactation study is needed and how to communicate the results to the public
• How to treat the pediatric population POSTER ABSTRACT SUBMISSION GUIDELINES Please email all poster abstracts directly to:
Karen King, Global Safety Manager, Maternal and Pediatric Safety (MAPS)
Amgen, Inc Direct: 805-447-8924 Fax: 805-498-2481 Email Address: kingk@amgen.com and be sure to copy: Joanne.Wallace@diahome.org All abstracts must be received by September 14, 2010.
Authors of selected abstracts will be notified by September 21, 2010
Event Code:
10032
|